I expected that becoming cancer-free would mean getting my old life back. Nothing could be further from the truth.

A recent trial reveals metformin does not enhance survival in metastatic prostate cancer but offers significant metabolic ...

New insights highlight how prostate cancer is now managed as a chronic disease, with emerging treatments and real-world data ...

With regard to the choice of bone-protecting agent, denosumab (Xgeva) improved bone density and reduced fracture risk in a ...

Androgen deprivation therapy (ADT) has long been a foundation in the management of prostate cancer. Since the introduction of ...

During a live event, Jahan Aghalar, MD, discussed the efficacy and safety of darolutamide plus ADT in mHSPC in the ARANOTE ...

Prostate cancer is one of the most common cancers in the world. While many prostate cancers grow slowly and remain localized, ...

In a significant advancement for prostate cancer research, a first-of-its-kind study led by Emory researchers uncovered how ...

A groundbreaking procedure known as aquablation therapy is transforming the treatment of a common health problem for men.

Men on active surveillance for low- to intermediate-risk prostate cancer (PCa) have low risk for PCa-related mortality at a median follow-up of 18 years. However, a majority of men do progress and ...

University of Michigan researchers identified a gene program associated with extreme non-response to the cancer drug ...